BuTrans (buprenorphine), a new once-a-week opioid patch for persistent pain

August 2010

You'll soon see BuTrans (buprenorphine), a new once-a-week opioid patch for persistent pain....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Diabetes whether Avandia is riskier than Actos
Neurology & Pain BuTrans (buprenorphine), a new once-a-week opioid patch for persistent pain
Neurology & Pain Onsolis will offer a new option for breakthrough cancer pain
Women's Health how to treat COMPLICATED vaginal yeast infections
Heart Failure aldosterone antagonists (spironolactone, eplerenone) for systolic heart failure
Dermatology Calcitriol (Silkis) ointment will be an alternative to calcipotriol (Dovonex, etc) for psoriasis
Dermatology Finacea (fin-AY-shuh) will be a new option for rosacea
Diabetes tighter control of blood glucose and lipids to slow the progression of diabetic retinopathy
Cardiology whether angiotensin receptor blockers increase cancer or cardiovascular risk
NSAIDs how to choose an NSAID based on GI and cardiovascular risks
Supplements Many supplements are promoted for diabetes
Pediatrics what dose of OTC meds to give to kids